Odyssey Health Inc
For the period ended Oct 31, 2024. Filed Dec 16, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2024 · Filed Dec 16, 2024
ODYYStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Deficit
| Shares | Dollars | Additional Paid-In Capital | Accumulated Deficit | Total (Deficit) | |
|---|---|---|---|---|---|
| Balances, July 31, 2024 | 96,709,763 | $96,710 | $55,572,687 | $(61,003,146) | $(5,333,749) |
| Stock-based compensation | – | – | 60,487 | – | 60,487 |
| Warrants issued in debt financing | – | – | 13,343 | – | 13,343 |
| Net loss | – | – | – | (1,018,906) | (1,018,906) |
| Balances, October 31, 2024 | 96,709,763 | $96,710 | $55,646,517 | $(62,022,052) | $(6,278,825) |
| Shares | Dollars | Additional Paid-In Capital | Accumulated Deficit | Total (Deficit) | |
|---|---|---|---|---|---|
| Balances, July 31, 2023 | 79,067,879 | $79,068 | $53,862,378 | $(60,097,375) | $(6,155,929) |
| Stock-based compensation | – | – | 322,728 | – | 322,728 |
| Common stock issued in debt financing | 655,792 | 656 | 78,039 | – | 78,695 |
| Common stock issued in equity financings | 500,000 | 500 | 45,320 | – | 45,820 |
| Warrants exercised in connection with debt financing | 1,610,390 | 1,610 | (1,610) | – | – |
| Warrants issued in debt financing | – | – | 28,448 | – | 28,448 |
| Return of shares | (100,000) | (100) | 100 | – | – |
| Net loss | – | – | – | (538,035) | (538,035) |
| Balances, October 31, 2023 | 81,734,061 | $81,734 | $54,335,403 | $(60,635,410) | $(6,218,273) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.